Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 32, Number 10—October 2026
Synopsis
Systematic Review and Meta-analysis of Group B Streptococcus Rectovaginal Colonization Rates and Serotype Distribution among Pregnant Women, Asia-Pacific Region, 2014–2025
, Lien Anh Ha Do, Darren Suryawijaya Ong, Claire von Mollendorf1, and Fiona M. Russell1
Table 1
Summary of included studies, according to country-income status, in study of group B Streptococcus rectovaginal colonization rates and serotype distribution among pregnant women, Asia-Pacific region, 2014–2025*
| Country income level | No. studies | Asia-Pacific region | Pregnant women tested, no. (range†) | Women with GBS colonization, no. (range†) | Studies with GBS serotyping data, no. (%) | Studies with AMR data, no. (%) | ROB score, median (IQR) |
|---|---|---|---|---|---|---|---|
| High income | 38 | 758,701 (79–318,740) | 149,899 (17–30,176) | 7 (18.4) | 10 (28.9) | 5 (4–6) | |
| Australia | 10 | Oceania | 89,828 (531–60,674) | 19,253 (106–13,058) | 1 (10.0) | 1 (10.0) | 5 (3.3–6) |
| Hong Kong, China | 6 | East Asia | 435,391 (134–318,740) | 89,173 (63–63,767) | 0 | 1 (16.7) | 5.5 (3.5–6.8) |
| Japan | 9 | East Asia | 6870 (79–1,957) | 1162 (17–423) | 4 (44.4) | 2 (22.2) | 6 (4–6) |
| South Korea | 6 | East Asia | 36,182 (150–33,721) | 3,856 (23–3,578) | 2 (33.3) | 3 (50.0) | 5.5 (5–6.8) |
| Taiwan |
7 |
East Asia |
190,430 (519–154,088) |
36,455 (113–30,176) |
0 |
3 (42.9) |
5 (4–6.5) |
| Upper-middle income | 38 | 210,333 (100–49,908) | 22,058 (19–5,902) | 10 (25.6) | 13 (33.3) | 5 (4–6) | |
| China | 33 | East Asia | 208,819 (116–49,908) | 21,668 (18–5,902) | 9 (26.5) | 11 (32.4) | 5 (4–6) |
| Indonesia | 2 | Southeast Asia | 336 (159–177) | 79 (26–53) | 1 (50.0) | 1 (50.0) | 5.5 (4.3–6.8) |
| Malaysia | 1 | Southeast Asia | 573 | 235 | 0 | 0 | 7 |
| Thailand |
2 |
Southeast Asia |
605 (100–505) |
76 (19–57) |
0 |
1 (50.0) |
6 (5.5–6.5) |
| Low and middle income | 31‡ | 13,727 (50–3,863) | 1,688 (0–310) | 8 (25.8) | 11 (35.5) | 5 (4–6) | |
| Bangladesh | 3 | South Asia | 1,375 (224–1,151) | 356 (46–172) | 2 (66.7) | 1 (33.3) | 5 (5–6.5) |
| India | 13 | South Asia | 4,687 (50–966) | 402 (0–174) | 2 (15.4) | 5 (38.5) | 5 (4–6) |
| Pakistan | 5 | South Asia | 839 (78–261) | 136 (18–48) | 1 (20.0) | 0 | 5 (4–6) |
| Sri Lanka | 4 | South Asia | 825 (150–250) | 142 (28–45) | 1 (25.0) | 3 (75.0) | 5 (4.5–5.3) |
| Vietnam |
6 |
Southeast Asia |
6,001 (50–3,863) |
652 (3−310) |
2 (33.3) |
2 (33.3) |
6 (4.5–6.5) |
| Total | 106‡ | 982,761 | 173,645 | 25 (23.5) | 34 (32.1) | 5 (4–6) |
*Expanded data are provided in Appendix Table 2. AMR, antimicrobial drug resistance; ANC, antenatal clinic; IQR, interquartile range; ROB, risk of bias. †Range indicates the number of persons included in each study. ‡One study contributed data to both Bangladesh and India; therefore, country-specific counts exceed the total number of included studies.
1These authors contributed equally to this article.